freenet AG (OTCMKTS:FRTAF – Get Free Report) saw a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 29,900 shares, an increase of 7.2% from the August 31st total of 27,900 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 299.0 days.
freenet Price Performance
Shares of FRTAF stock opened at $26.87 on Wednesday. The business has a fifty day simple moving average of $26.98 and a 200 day simple moving average of $27.08. The company has a market cap of $3.44 billion, a P/E ratio of 14.52 and a beta of 0.40. The company has a quick ratio of 0.62, a current ratio of 0.67 and a debt-to-equity ratio of 0.31. freenet has a twelve month low of $26.87 and a twelve month high of $26.87.
freenet (OTCMKTS:FRTAF – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.69 earnings per share (EPS) for the quarter. The company had revenue of $651.55 million for the quarter. freenet had a net margin of 8.56% and a return on equity of 18.16%.
freenet Company Profile
freenet AG provides telecommunications, broadcasting, and multimedia services for mobile communications/mobile internet, and digital lifestyle sectors in Germany. It operates through Mobile Communications, TV and Media, and Other/Holding segments. The Mobile Communications segment engages in the marketing of mobile communications services, which include voice and data services from the mobile network operators; planning, set up, installation, and maintenance services for WiFi networks; and selling and distribution of mobile devices, as well as offers additional services for mobile data communications and digital lifestyle.
See Also
- Five stocks we like better than freenet
- What is Put Option Volume?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Investors Need to Know to Beat the Market
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for freenet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for freenet and related companies with MarketBeat.com's FREE daily email newsletter.